Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Value Stock, Under Radar

375.0500 -1.45 (-0.39%)

NSE Jan 20, 2026 15:31 PM

33.51% Fall from 52W High

Volume: 152.7K

Aarti Drugs Ltd.

30 Oct 2022

375.05

-0.39%

Result Update:Aarti Drugs

Buy: Aarti Drugs Ltd.

Recommendation Target

Axis Direct

Aarti Drugs could be benefitted in upcoming quarters, we upgrade to BUY on Aarti Drugs with Target Price of Rs 545

Aarti Drugs has lost -27.55% in the last 3 Months